Detalles de la búsqueda
1.
Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system.
Am J Obstet Gynecol
; 230(5): 548.e1-548.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295968
2.
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial.
AIDS Behav
; 2024 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38852114
3.
In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.
Antimicrob Agents Chemother
; 60(9): 5459-66, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27381393
4.
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
AIDS Behav
; 20(11): 2565-2577, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26204987
5.
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
PLoS Med
; 12(1): e1001778, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25612136
6.
Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India).
AIDS Behav
; 19(2): 369-79, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25384905
7.
To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Cult Health Sex
; 17(8): 1004-20, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25913101
8.
Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe.
BMJ Open
; 14(3): e075381, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38479746
9.
Use of the dye stain assay and ultraviolet light test for assessing vaginal insertion of placebo-filled applicators before and after sex.
Sex Transm Dis
; 40(12): 939-43, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24220355
10.
Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials.
Sex Transm Dis
; 40(12): 950-6, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24220357
11.
How informed are clients who consent? A mixed-method evaluation of comprehension among clients of male circumcision services in Zambia and Swaziland.
AIDS Behav
; 17(6): 2269-82, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23392912
12.
Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.
AIDS Behav
; 17(2): 585-97, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22907287
13.
An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India.
AIDS Behav
; 17(6): 2222-36, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23299877
14.
Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology.
PLoS One
; 18(8): e0290568, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651432
15.
New approaches for developing biomarkers of hormonal contraceptive use.
Sci Rep
; 13(1): 245, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604469
16.
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
PLoS One
; 18(6): e0287525, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37352296
17.
Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).
AIDS Educ Prev
; 34(4): 257-271, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35994578
18.
Results of a phase 1, randomized, placebo-controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel.
PLoS One
; 17(1): e0261775, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051209
19.
The Promise of the Dual Prevention Pill: A Framework for Development and Introduction.
Front Reprod Health
; 32021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318291
20.
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake.
BMJ Sex Reprod Health
; 47(3): 166-172, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32737137